196 related articles for article (PubMed ID: 18336339)
1. Relationship between drugs and functional activity of various mammalian P-glycoproteins (ABCB1).
Kim IW; Booth-Genthe C; Ambudkar SV
Mini Rev Med Chem; 2008 Mar; 8(3):193-200. PubMed ID: 18336339
[TBL] [Abstract][Full Text] [Related]
2. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
Haufroid V
Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
[TBL] [Abstract][Full Text] [Related]
4. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses.
Ishikawa T; Hirano H; Onishi Y; Sakurai A; Tarui S
Drug Metab Pharmacokinet; 2004 Feb; 19(1):1-14. PubMed ID: 15499164
[TBL] [Abstract][Full Text] [Related]
6. The P-glycoprotein repertoire of the equine parasitic nematode Parascaris univalens.
Gerhard AP; Krücken J; Heitlinger E; Janssen IJI; Basiaga M; Kornaś S; Beier C; Nielsen MK; Davis RE; Wang J; von Samson-Himmelstjerna G
Sci Rep; 2020 Aug; 10(1):13586. PubMed ID: 32788636
[TBL] [Abstract][Full Text] [Related]
7. Determining P-glycoprotein-drug interactions: evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayers.
Melchior DL; Sharom FJ; Evers R; Wright GE; Chu JW; Wright SE; Chu X; Yabut J
J Pharmacol Toxicol Methods; 2012 Mar; 65(2):64-74. PubMed ID: 22394995
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.
Hochman JH; Yamazaki M; Ohe T; Lin JH
Curr Drug Metab; 2002 Jun; 3(3):257-73. PubMed ID: 12083320
[TBL] [Abstract][Full Text] [Related]
9. Drugs as P-glycoprotein substrates, inhibitors, and inducers.
Kim RB
Drug Metab Rev; 2002; 34(1-2):47-54. PubMed ID: 11996011
[No Abstract] [Full Text] [Related]
10. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity.
Mechetner EB; Schott B; Morse BS; Stein WD; Druley T; Davis KA; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12908-13. PubMed ID: 9371774
[TBL] [Abstract][Full Text] [Related]
11. Utility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and development.
Chen C; Liu X; Smith BJ
Curr Drug Metab; 2003 Aug; 4(4):272-91. PubMed ID: 12871045
[TBL] [Abstract][Full Text] [Related]
12. Role of P-glycoprotein in drug disposition.
Tanigawara Y
Ther Drug Monit; 2000 Feb; 22(1):137-40. PubMed ID: 10688277
[TBL] [Abstract][Full Text] [Related]
13. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
Han LW; Gao C; Mao Q
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
[TBL] [Abstract][Full Text] [Related]
14. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
Kwon H; Lionberger RA; Yu LX
Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
[TBL] [Abstract][Full Text] [Related]
15. Use of shape similarities for the classification of P-glycoprotein substrates and nonsubstrates.
Schwaha R; Ecker GF
Future Med Chem; 2011 Jul; 3(9):1117-28. PubMed ID: 21806376
[TBL] [Abstract][Full Text] [Related]
16. Predicting P-glycoprotein effects on oral absorption: correlation of transport in Caco-2 with drug pharmacokinetics in wild-type and mdr1a(-/-) mice in vivo.
Collett A; Tanianis-Hughes J; Hallifax D; Warhurst G
Pharm Res; 2004 May; 21(5):819-26. PubMed ID: 15180340
[TBL] [Abstract][Full Text] [Related]
17. Macrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assay.
Kaschny M; Demeler J; Janssen IJ; Kuzmina TA; Besognet B; Kanellos T; Kerboeuf D; von Samson-Himmelstjerna G; Krücken J
PLoS Pathog; 2015 Apr; 11(4):e1004781. PubMed ID: 25849454
[TBL] [Abstract][Full Text] [Related]
18. Using the lentiviral vector system to stably express chicken P-gp and BCRP in MDCK cells for screening the substrates and studying the interplay of both transporters.
Zhang Y; Huang J; Liu Y; Guo T; Wang L
Arch Toxicol; 2018 Jun; 92(6):2027-2042. PubMed ID: 29725709
[TBL] [Abstract][Full Text] [Related]
19. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
20. A review on the relation between the brain-serum concentration ratio of drugs and the influence of P-glycoprotein.
Ejsing TB; Morling N; Linnet K
Drug Metabol Drug Interact; 2007; 22(2-3):113-29. PubMed ID: 17708063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
